2,16 Despite this, DUX4 target gene biomarkers associate with FSHD status, particularly in the context of active inflammation (e.g. STIR/TIRM positivity on MRI).17-22. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.